These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4977284)

  • 1. Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state.
    Gotschlich EC; Goldschneider I; Artenstein MS
    J Exp Med; 1969 Jun; 129(6):1385-95. PubMed ID: 4977284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningococcal carriage and vaccination in army recruits in Italy.
    Di Martino M; Calì G; Astorre P; Usai GC; Ferrari R; Stroffolini T
    Boll Ist Sieroter Milan; 1990; 69(1):357-9. PubMed ID: 2129323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of meningococcal group A and C polysaccharide vaccine on nasopharyngeal carrier state.
    Stroffolini T; Angelini L; Galanti I; Occhionero M; Congiu ME; Mastrantonio P
    Microbiologica; 1990 Jul; 13(3):225-9. PubMed ID: 2125684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunity to the meningococcus. II. Development of natural immunity.
    Goldschneider I; Gotschlich EC; Artenstein MS
    J Exp Med; 1969 Jun; 129(6):1327-48. PubMed ID: 4977281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of group-A meningococcal vaccine in army recruits in Finland.
    Mäkelä PH; Käyhty H; Weckström P; Sivonen A; Renkonen OV
    Lancet; 1975 Nov; 2(7941):883-6. PubMed ID: 53370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of meningococcal disease by group C polysaccharide vaccine.
    Artenstein MS; Gold R; Zimmerly JG; Wyle FA; Schneider H; Harkins C
    N Engl J Med; 1970 Feb; 282(8):417-20. PubMed ID: 4983754
    [No Abstract]   [Full Text] [Related]  

  • 7. Meningococcal polysaccharide vaccination of military recruits in Israel: preliminary assessment of vaccine effect.
    Mimouni D; Gdalevich M; Mandel Y; Haim M; Ashkenazi I; Shemer J; Block C
    Scand J Infect Dis; 1998; 30(3):263-4. PubMed ID: 9790134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunity to the meningococcus. I. The role of humoral antibodies.
    Goldschneider I; Gotschlich EC; Artenstein MS
    J Exp Med; 1969 Jun; 129(6):1307-26. PubMed ID: 4977280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenicity of a polysaccharide vaccine from Neisseria meningitidis administered intranasally.
    Wenzel RP; Mitzel JR; Davies JA; Edwards EA; Berling C; McCormick DP; Beam WE
    J Infect Dis; 1973 Jul; 128(1):31-40. PubMed ID: 4198026
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy.
    Occhionero M; Usai G; Di Martino M; Le Moli S; Stroffolini T; Mastrantonio P
    Allergol Immunopathol (Madr); 1991; 19(1):39-41. PubMed ID: 1950941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of meningococcal meningitis with meningococcal vaccines.
    Artenstein MS
    Yale J Biol Med; 1975 Jul; 48(3):197-200. PubMed ID: 808913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of group C meningococcal polysaccharide vaccine in marine recruits, San Diego, California.
    Devine LF; Pierce WE; Floyd TM; Rhode SL; Edwards EA; Siess EE; Peckinpaugh RO
    Am J Epidemiol; 1970 Jul; 92(1):25-32. PubMed ID: 4987716
    [No Abstract]   [Full Text] [Related]  

  • 13. In-vitro and in-vivo studies of resistance to rifampin in meningococci.
    Eickhoff TC
    J Infect Dis; 1971 Apr; 123(4):414-20. PubMed ID: 4999905
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and serological evaluation of a meningococcal polysaccharide vaccine groups A, C, Y, and W135.
    Hankins WA; Gwaltney JM; Hendley JO; Farquhar JD; Samuelson JS
    Proc Soc Exp Biol Med; 1982 Jan; 169(1):54-7. PubMed ID: 6801667
    [No Abstract]   [Full Text] [Related]  

  • 15. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
    Cohen R; Levy C
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S61-4. PubMed ID: 22883368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal antibody after colonization with Neisseria meningitidis.
    Reller LB; MacGregor RR; Beaty HN
    J Infect Dis; 1973 Jan; 127(1):56-62. PubMed ID: 4630238
    [No Abstract]   [Full Text] [Related]  

  • 17. [Meningococcus group carrier status in Chinese recruits].
    Yang YF; Chen CP; Tai FH
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1976 Dec; 9(3-4):49-54. PubMed ID: 829418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sero-epidemiologic studies of meningococcal infection with the direct hemagglutination test.
    Eickhoff TC
    J Infect Dis; 1971 May; 123(5):519-26. PubMed ID: 4329898
    [No Abstract]   [Full Text] [Related]  

  • 19. Meningococcal disease and its control with meningococcal polysaccharide vaccines.
    Galazka A
    Bull World Health Organ; 1982; 60(1):1-7. PubMed ID: 6979414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom.
    Zhang Q; Lakshman R; Burkinshaw R; Choo S; Everard J; Akhtar S; Finn A
    Infect Immun; 2001 Jul; 69(7):4337-41. PubMed ID: 11401971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.